{"id":"noradrenaline-and-vascular-filling","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Tachycardia"},{"rate":"5-10%","effect":"Hypertension"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Nausea"},{"rate":"2-5%","effect":"Vomiting"},{"rate":"2-5%","effect":"Dizziness"},{"rate":"2-5%","effect":"Palpitations"},{"rate":"1-2%","effect":"Tremors"},{"rate":"1-2%","effect":"Angina"},{"rate":"1-2%","effect":"Chest pain"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This results in increased blood pressure and cardiac output. Noradrenaline also has a positive inotropic effect, increasing the force of cardiac contractions.","oneSentence":"Noradrenaline increases vascular tone and cardiac contractility by stimulating alpha-1 adrenergic receptors.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:23:28.233Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypotension"},{"name":"Anaphylactic shock"}]},"trialDetails":[{"nctId":"NCT03828565","phase":"NA","title":"Decrease of Post-operative Complications by SCVO2 Monitoring an Optimisation of Cardiac Flow","status":"COMPLETED","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2019-03-01","conditions":"Cardiac Flow","enrollment":220},{"nctId":"NCT02116413","phase":"","title":"Does the Time Between the End of Vascular Filling and Evaluation of Its Effectiveness Modify Fluid Challenge Results in Septic Shock?","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2014-05","conditions":"Septic Shock","enrollment":145},{"nctId":"NCT03852147","phase":"NA","title":"Individualized Hemodynamic Optimization by Indirect Measurement of the Respiratory Quotient in Major Surgery: Prospective Randomized Multicentre Open-Label Study (OPHIQUE) Individualized Optimization by Indirect Measurement of the Respiratory Quotient","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2018-12-26","conditions":"Post-Op Complication, Respiratory Complication","enrollment":350},{"nctId":"NCT05481723","phase":"PHASE3","title":"Lung Ultrasound-guided Hemodynamic Optimization","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2022-07-28","conditions":"Lung Ultrasound, Goal Directed Therapy, Non-cardiac Surgery","enrollment":350}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":8,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"noradrenaline and vascular filling","genericName":"noradrenaline and vascular filling","companyName":"Centre Hospitalier Universitaire, Amiens","companyId":"centre-hospitalier-universitaire-amiens","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Noradrenaline increases vascular tone and cardiac contractility by stimulating alpha-1 adrenergic receptors. Used for Hypotension, Anaphylactic shock.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}